Cargando…
New insights into the interaction of the immune system with non-small cell lung carcinomas
The basis of current and future lung cancer immunotherapy depends mainly on our knowledge of the molecular mechanisms of interactions between cancer and immune cells (ICs), as well as on interactions occurring between the different populations of intra-tumor ICs. These interactions are very complex,...
Autor principal: | Hofman, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653157/ https://www.ncbi.nlm.nih.gov/pubmed/33209644 http://dx.doi.org/10.21037/tlcr-20-178 |
Ejemplares similares
-
Outsourcing predictive biomarker testing in non-small cell carcinoma: a personal view of pathologists
por: Brcic, Luka, et al.
Publicado: (2020) -
New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts
por: Lantuejoul, Sylvie, et al.
Publicado: (2020) -
New developments in lung cancer diagnosis and pathological patient management strategies
por: Popper, Helmut
Publicado: (2020) -
How should molecular findings be integrated in the classification for lung cancer?
por: Hung, Yin P., et al.
Publicado: (2020) -
A narrative review of digital pathology and artificial intelligence: focusing on lung cancer
por: Sakamoto, Taro, et al.
Publicado: (2020)